ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 561

Comprehensive Immuno-Phenotyping of Follicular Helper T Cell and B Cell Subpopulations in Primary Sjögren’s Syndrome

Nida Meednu1, Cécile Seifert2, Jennifer Barnard3, Madhu Ramaswamy4, Jeffrey Riggs5, Alex Rosenberg6, Jamie Biear7, Gianluca Carlesso4, Ralf G. Thiele8, Andreea Coca9, Fanny Monneaux2, Helene Dumortier2, Jacques-Eric Gottenberg2 and Jennifer H. Anolik1, 1Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 2CNRS, Immunopathologie et Chimie Thérapeutique/Laboratory of Excellence Medalis, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France, 3Medicine-Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 4MedImmune LLC, Gaithersburg, MD, 5Respiratory, Inflammation and Autoimmunity (RIA), MedImmune LLC, Gaithersburg, MD, 6Department of Microbiology and Informatics Institute, University of Alabama at Birmingham, Birmingham, AL, 7Rheumatology, University of Rochester Medical Center, Rochester, NY, 8Medicine, University of Rochester Medical Center, Rochester, NY, 9University of Rochester Medical Center, Rochester, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: B cells, Sjogren's syndrome and T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Sjögren's Syndrome Poster I: Translational Research

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized by immune cell infiltration in the salivary glands resulting in ocular and oral dryness. Abnormalities in B cell activation and skewing of T cell polarization toward Th2 and T follicular helper (TFH) associated with ectopic germinal center formation in the salivary gland are observed in pSS. However, the interplay between B and T cell subsets, and other immune abnormalities, as well as relationship to disease status, has yet to be fully elucidated. In this study, we evaluated changes in peripheral blood B and T cell populations in pSS compared to SLE and RA diseases and healthy controls.

Methods: Two cohorts of patients with pSS according to European-American Consensus and ACR criteria and age-matched healthy controls (HC) were recruited (Rochester, USA and Strasbourg, France) and disease activity assessed by ESSDAI and ESSPRI. The Rochester cohort also included RA (n=20) and SLE (n=15) classified based on ACR criteria. PBMCs were isolated by Ficoll-Hypaque and the frequencies of B and T subpopulations measured by multi-parameter flow cytometry. Data are reported as median [25th-75th quartile]. Correlation analysis was done by Pearson method, p < 0.05 was considered significant.

Results: We examined the expression of ICOS and PD-1, two important co-regulatory molecules of the B7-family, on memory T cells (CD4+CD45RA-) in pSS compare to HC, SLE and RA. pSS and SLE had higher frequency of memory T cells expressing both ICOS and PD-1 than HC while RA had higher frequency of PD-1+/hi T cells. Accordingly, T follicular helper cells (TFH: CXCR5+ICOS+PD-1+) were found at higher frequency in pSS and SLE compared to HC (pSS (n=40): 5.96 [3.75-8.71]%; HC (n=58): 4.18 [2.51-4.91]%, p=0.0005; SLE (n=15): 4.61 [3.51-9.84]%, p=0.002). Further evaluation of TFH subsets (based on CXCR3 and CCR6), revealed higher frequency of TFH1 and lower TFH17 subset in pSS compare to HC and RA, also confirmed in the Strasbourg cohort. Characterization of B cells in pSS patients from Rochester cohort revealed significant contractions of switched memory (SM) and un-switched memory (USM) B cell compared to HC (pSS SM (n=39): 3.52 [1.65-7.28]%; HC SM (n=38): 7.57 [5.49-10.86]%, p=0.005; pSS USM (n=39): 10.07 [5.47-15.62]%; HC USM (n=38): 21.44 [15.16-31.27]%, p<0.0001). Furthermore, frequencies of ICOSL expressing SM and USM were lower in pSS than HC. There was a significant inverse correlation between ICOSL+ USM B cells and TFH1 in pSS patients (ρ= -0.55, p=0.0255). There were two distinct clusters of pSS based on T and B cell subsets, with one group distinct from HC and associated with higher disease activity and autoantibodies. In a subset of pSS (n=10), T and B cell frequencies were evaluated longitudinally at 6 months. Significant changes in frequency of ICOSL+ B cells were observed and negatively correlated with changes in CXCR5+ICOS+ T cells (ρ= -0.634, p=0.049).

Conclusion: Our data highlight the significant abnormalities in the peripheral TFH and B cell compartment in pSS and further suggest the critical role of TFH- B cell interactions. The decrease in ICOSL+ memory B cells suggests interaction with ICOS+ T cells in germinal center-like structures in salivary glands.


Disclosure: N. Meednu, None; C. Seifert, None; J. Barnard, None; M. Ramaswamy, MedImmune LLC, 3; J. Riggs, MedImmune, LLC, 3,AstraZeneca, 1; A. Rosenberg, None; J. Biear, None; G. Carlesso, MedImmune LLC, 3; R. G. Thiele, Amgen, 8,AbbVie, 8,BioClinica, 5,Fujifilm SonoSite, 9; A. Coca, None; F. Monneaux, None; H. Dumortier, None; J. E. Gottenberg, BMS, Gilead, Medimune,Pfzer SanofiAventis, Ucb, 2; J. H. Anolik, None.

To cite this abstract in AMA style:

Meednu N, Seifert C, Barnard J, Ramaswamy M, Riggs J, Rosenberg A, Biear J, Carlesso G, Thiele RG, Coca A, Monneaux F, Dumortier H, Gottenberg JE, Anolik JH. Comprehensive Immuno-Phenotyping of Follicular Helper T Cell and B Cell Subpopulations in Primary Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/comprehensive-immuno-phenotyping-of-follicular-helper-t-cell-and-b-cell-subpopulations-in-primary-sjogrens-syndrome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comprehensive-immuno-phenotyping-of-follicular-helper-t-cell-and-b-cell-subpopulations-in-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology